Main Page Tenders by countries Germany: Tenders

Ab­schluss nicht-ex­klu­si­ver Arz­nei­mit­tel-Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells zum Wirk­stoff Tol­vap­tan (amt­li­cher ATC-Code: C03XA01) (Tender №49453588)

PUSH for registration

Share:
Country: Germany
Language: DE
Number: 49453588
Publication date: 14-10-2021
Source:

Link to original

to view information You need to subscribe to the portal

Description

Full information on the tender is closed.
For further work with the site read the information below.

About us

Leading searching system of world tenders

  • Largest database of tenders and sources of procurement of the World
  • Free daily mailings according to Your settings
  • Winners information
  • Convenient display and downloading of information

Choose us

Getting Started

After site registration, this functions will be available to You

  • Subscription to free mailing list for your keyword phrases
  • Tenders announcements previews
  • Download summary information in Excel format
  • View information about tender winners, suppliers and customers

REGISTER

For using all functions of our site and view full information you need to register a commercial account

  • Selected period
  • Pay access in any of the possible ways

Get full access

Other tenders for this period

Ab­schluss nicht-ex­klu­si­ver Arz­nei­mit­tel-Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells zum Wirk­stoff Die­no­gest (ATC-Code nach WHO: G03DB08) Source: Bund.de

Ab­schluss nicht-ex­kl. AM-Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells zur Wirk­stoff­kom­bi­na­ti­on Cal­ci­po­tri­ol/Be­ta­me­tha­son (ATC-Code WHO: D05AX52; amtl.: D05AX22) Source: Bund.de

Ab­schluss nicht-ex­klu­si­ver Arz­nei­mit­tel-Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells zum Wirk­stoff Lan­than(III)-car­bo­nat (ATC-Code nach WHO: V03AE03) Source: Bund.de

Ab­schluss nicht-ex­klu­si­ver Arz­nei­mit­tel-Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells zum Wirk­stoff Roflu­mi­last (ATC-Code nach WHO: R03DX07) Source: Bund.de

Ab­schluss nicht-ex­klu­si­ver Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells für AM mit dem Wirk­stoff Ami­fam­pri­din (ATC-Code nach WHO: N07XX05) Source: Bund.de

Ab­schluss nicht-ex­klu­si­ver Arz­nei­mit­tel-Ra­batt­ver­ein­ba­run­gen nach § 130a Abs. 8 SGB V im We­ge ei­nes sog. Open-Hou­se-Mo­dells zum Wirk­stoff Die­no­gest/Ethi­ny­le­stra­di­ol (ATC-Code nach WHO: G03AA16) Source: Bund.de